IP Verse

Rigel Pharmaceuticals, Inc. opposition analysis

COMPANY ANALYSIS

Latest patents of Rigel Pharmaceuticals, Inc. opposed by its competitors

Patent:
EP2736487
Grant Date:
Aug 28, 2024
Title:
New (Trimethoxyphenylamino)Pyrimidinyl Formulations
Oppositions:
1

Competitors of Rigel Pharmaceuticals, Inc.

TEVA PHARMACEUTICAL INDUSTRIES LTD.

Want to track Rigel Pharmaceuticals, Inc.?

Feel free to send us a message here and we will get back to you